Leading the Charge

We’ve built a company poised to produce transformative pharmaceutical solutions by bringing together leaders steeped in all the functional areas needed to bring new drugs to life. With a deeply skilled management team directing our day-to-day wins, and a Board with a stellar track record, we’re acquiring, developing and commercializing drug candidates for diseases where there is a high unmet medical need.

The Backbone of our Innovation

The Dova Board brings impressive experience to the table, bright minds from across the spectrum of relevant disciplines helping to illuminate the path forward for our pharmaceutical solutions.

Steven M. Goldman

Steven M. Goldman

Joined Dova Board: May 2017

Mr. Goldman is a Partner of Kramer Levin Naftalis & Frankel LLP, specializing in mergers and acquisitions, financings, joint ventures, private placements, leveraged buyouts and general corporate counseling. He has represented numerous banks in connection with financing of acquisitions and recapitalizations, and insurance brokerages in connection with regulatory enforcement issues and in purchase and sale transactions. From 2006 to 2009, before joining Kramer Levin, Mr. Goldman was the State of New Jersey’s Department of Banking and Insurance Commissioner, appointed by Governor Jon S. Corzine. He has held a number of other esteemed professional and civic roles, including serving on the Dean’s Board of Advisors for The George Washington University Law School. He is also a member of the board of directors, the Executive Committee, and the Operations and Finance Committee and Assistant Treasurer of the New Jersey Performing Arts Center, and Chairs the Board of Managers of Theatre Square Development Company, LLC (the real estate development subsidiary of the NJ Performing Arts Center). Mr. Goldman received his A.B. in Political Science from Boston University, his J.D. from the George Washington University and his L.L.M. in taxation from New York University.